Molecular Partners AG Sponsored ADR (MOLN)
(Delayed Data from NSDQ)
$4.67 USD
0.00 (0.00%)
Updated Sep 19, 2024 10:29 AM ET
After-Market: $4.96 +0.29 (6.21%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth A Momentum D VGM
Income Statements
Fiscal Year end for Molecular Partners AG Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 8 | 199 | 11 | 10 | NA |
Cost Of Goods | 54 | 53 | 61 | 60 | NA |
Gross Profit | -47 | 146 | -50 | -50 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 22 | 23 | 19 | 12 | 0 |
Income After Depreciation & Amortization | -68 | 122 | -69 | -62 | 0 |
Non-Operating Income | 5 | 2 | 0 | 0 | NA |
Interest Expense | 6 | 1 | 1 | 5 | NA |
Pretax Income | -69 | 124 | -70 | -67 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -69 | 124 | -70 | -67 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -69 | 124 | -70 | -67 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -65 | 125 | -67 | -59 | 0 |
Depreciation & Amortization (Cash Flow) | 3 | 3 | 3 | 3 | NA |
Income After Depreciation & Amortization | -68 | 122 | -69 | -62 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 32.77 | 33.28 | 30.96 | NA | NA |
Diluted EPS Before Non-Recurring Items | -2.10 | 3.71 | -2.25 | NA | NA |
Diluted Net EPS (GAAP) | -2.11 | 3.71 | -2.25 | -2.68 | NA |
Fiscal Year end for Molecular Partners AG Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1.71 | 3.13 | 1.21 | 2.88 | 0.46 |
Cost Of Goods | 14.47 | 16.12 | 14.54 | 13.14 | 12.94 |
Gross Profit | -12.76 | -12.99 | -13.34 | -10.26 | -12.48 |
SG&A, R&D, and Dept/Amort Expenses | 4.91 | 5.13 | 5.49 | 5.01 | 5.19 |
Income After SG&A, R&D, and Dept/Amort Expenses | -17.67 | -18.12 | -18.83 | -15.27 | -17.67 |
Non-Operating Income | 1.01 | 5.19 | 0.29 | 2.33 | 1.21 |
Interest Expense | 0.02 | 0.01 | 3.80 | 0.01 | 1.33 |
Pretax Income | -16.68 | -12.95 | -22.34 | -12.95 | -17.78 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -16.68 | -12.95 | -22.34 | -12.95 | -17.78 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -16.68 | -12.95 | -22.34 | -12.95 | -17.78 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 33.18 | 32.87 | 32.77 | 32.74 | 32.63 |
Diluted EPS Before Non-Recurring Items | -0.51 | -0.39 | -0.68 | -0.40 | -0.55 |
Diluted Net EPS (GAAP) | -0.51 | -0.39 | -0.68 | -0.40 | -0.55 |